• Form 144 4D Molecular Therapeutics For: 9 July By Investing.com Investing.com Canada Thu, 09 Jul 2026 21:32:40 GMT
• 4D Molecular Therapeutics (FDMT) Edges Higher Amid Modest Gains - Factor Crowding dars.gov.et Tue, 07 Jul 2026 22:30:12 GMT
• Price to earnings forward of 4D Molecular Therapeutics, Inc. – NASDAQ:FDMT TradingView Sun, 05 Jul 2026 04:05:42 GMT
• FDMT (NASDAQ: FDMT) CLO sells 6,566 shares, exercises options under 10b5-1 plan Stock Titan Thu, 02 Jul 2026 20:08:53 GMT
• h.c. wainwright maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $36 富途牛牛 Thu, 02 Jul 2026 13:08:08 GMT
• Form 144 4D Molecular Therapeutics For: 30 June By Investing.com Investing.com Canada Tue, 30 Jun 2026 22:21:27 GMT
• FDMT (NASDAQ: FDMT) insider 10b5-1 sale of 9,810 shares for $117,720 Stock Titan Tue, 30 Jun 2026 20:39:19 GMT
• 4d molecular therapeutics to present 2-year phase 2b trial results of gene therapy 4d-150 for wet amd at asrs 2026 Pluang Tue, 30 Jun 2026 20:27:31 GMT
• 4DMT to present 2-year PRISM trial follow-up at retina meeting Stock Titan Tue, 30 Jun 2026 20:05:00 GMT
• 4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists Moomoo Tue, 30 Jun 2026 20:05:00 GMT
• 4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD Ophthalmology Times Europe Tue, 30 Jun 2026 15:10:07 GMT
• H.C. Wainwright reiterates Buy on 4D Molecular stock on trial progress Investing.com Tue, 30 Jun 2026 12:06:32 GMT
• morgan stanley maintains 4d molecular therapeutics(fdmt.us) with hold rating Moomoo Tue, 30 Jun 2026 11:33:00 GMT
• H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36 Moomoo Tue, 30 Jun 2026 07:00:00 GMT
• 4DMT Completes 4FRONT-2 Enrollment for 4D-150 Gene Therapy in Wet AMD The Clinical Trial Vanguard Tue, 30 Jun 2026 06:53:10 GMT
• 4DMT Secures Strategic Credit Facility for up to $200MM from Hercules Capital ABF Journal Tue, 30 Jun 2026 04:31:55 GMT
• 4D Molecular Therapeutics Shares Rise After New Credit Facility Moomoo Mon, 29 Jun 2026 14:34:00 GMT
• 4D Molecular (FDMT) Completes Enrollment for Phase 3 Clinical Tr GuruFocus Mon, 29 Jun 2026 13:09:24 GMT
• 4D Molecular Therapeutics Completes Enrollment for 4Front-2 Global Phase 3 Clinical Trial of 4D-150 in Wet Amd marketscreener.com Mon, 29 Jun 2026 13:06:28 GMT
• 4D Molecular Therapeutics Secures Strategic Credit Facility for Up to $200 Million from Hercules Capital marketscreener.com Mon, 29 Jun 2026 13:06:00 GMT
• 4D Molecular Therapeutics Secures Up to $200 Million Term Loan Facility From Hercules Capital TradingView Mon, 29 Jun 2026 12:13:01 GMT
• 4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD The Manila Times Mon, 29 Jun 2026 12:05:20 GMT
• 4DMT finishes Phase 3 enrollment for wet AMD gene therapy trial Stock Titan Mon, 29 Jun 2026 12:00:00 GMT
• press release: 4dmt secures strategic credit facility for up to $200 million from hercules capital Moomoo Mon, 29 Jun 2026 12:00:00 GMT
• 4D Molecular Therapeutics secures $200M credit facility Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• 4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics (FDMT) signs up to $200M secured loan with Hercules Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics, Inc. Actuals & Estimates (NASDAQ:FDMT) TradingView Mon, 29 Jun 2026 06:04:17 GMT
• 4D Molecular Therapeutics (FDMT) Inches Higher as Biotech Sector Watches Key Levels - Entry Point Alerts dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics clo scott bizily sells $117,720 in stock Investing.com UK Fri, 26 Jun 2026 03:05:07 GMT
• Form 4 4D Molecular Therapeutics Inc For: 25 June By Investing.com Investing.com Nigeria Fri, 26 Jun 2026 02:38:54 GMT
• form 4 4d molecular therapeutics inc for: 25 june by investing.com Investing.com Canada Thu, 25 Jun 2026 20:51:25 GMT
• 4d molecular therapeutics, inc. actuals & estimates (nasdaq:fdmt) TradingView Thu, 25 Jun 2026 18:06:56 GMT
• Retinitis Pigmentosa Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | SparingVision SAS... Barchart.com Thu, 25 Jun 2026 12:30:18 GMT
• 4D Molecular (NASDAQ: FDMT) CLO exercises options, sells 9,810 shares at $12 Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics CLO Scott Bizily sells $117,720 in stock Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• Form 144 4D Molecular Therapeutics For: 23 June By Investing.com Investing.com Nigeria Wed, 24 Jun 2026 02:45:22 GMT
• 4d molecular therapeutics ceo david kirn sells $1.2m in stock Investing.com UK Wed, 24 Jun 2026 01:28:29 GMT
• form 4 4d molecular therapeutics inc for: 23 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 00:01:11 GMT
• insider sell alert: david kirn sells 114,746 shares of 4d molecu GuruFocus Tue, 23 Jun 2026 22:36:28 GMT
• Form 4 4D Molecular Therapeutics Inc For: 23 June By Investing.com Investing.com UK Tue, 23 Jun 2026 20:32:00 GMT
• Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength? Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics CEO David Kirn sells $1.2m in stock Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• Insider David Kirn sells 114,746 4D Molecular Therapeutics (FDMT) shares Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics, Inc. announced that it expects to receive $200 million in funding marketscreener.com Tue, 23 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics | 4: statement of changes in beneficial ownership of securities-officer kirn david Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• form 144 4d molecular therapeutics for: 22 june by investing.com Investing.com Australia Tue, 23 Jun 2026 02:05:47 GMT
• form 144 4d molecular therapeutics for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 22:04:00 GMT
• form 8k 4d molecular therapeutics inc for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 21:14:19 GMT
• 4D Molecular Therapeutics (NASDAQ: FDMT) investors approve directors, auditor and pay Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics stockholders elect directors and approve proposals at annual meeting Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• David Kirn reports sale of 1,922 FDMT shares via Goldman Sachs (FDMT) Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics inc (fdmt) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics (fdmt) grants director john f. milligan 75,000 options Stock Titan Thu, 18 Jun 2026 21:32:39 GMT
• age-related macular degeneration clinical trial pipeline: GlobeNewswire Thu, 18 Jun 2026 17:00:00 GMT
• 4d molecular therapeutics inc (fdmt) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 11:28:08 GMT
• 4d molecular therapeutics inc (fdmt) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:58:34 GMT
• 4d molecular therapeutics inc (fdmt) institutional confidence TradingKey Thu, 18 Jun 2026 09:57:19 GMT
• 4d molecular therapeutics inc (fdmt) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:54:24 GMT
• 4D Molecular Therapeutics Inc (FDMT) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey Thu, 18 Jun 2026 09:52:27 GMT
• 4d molecular therapeutics inc (fdmt) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:27:02 GMT
• 4D Molecular (NASDAQ: FDMT) director gets 50,000 stock options grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4D Molecular Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THEUER CHARLES Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• Director at 4D Molecular Therapeutics (NASDAQ: FDMT) receives 50,000 options Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4d molecular (nasdaq: fdmt) grants director 50,000 stock options Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics (fdmt) director receives 50,000-share stock option grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics (fdmt) director granted 50,000 stock options with cic vesting Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4d molecular (fdmt) grants director 50,000 stock options at $9.42 Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics inc annual shareholders meeting transcript GuruFocus Wed, 17 Jun 2026 17:30:00 GMT
• Fabry Disease Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | Sanofi Genzyme, Sangamo ... Barchart.com Wed, 10 Jun 2026 07:00:00 GMT
• fdmt: gene therapy 4d-150 targets lifelong vision benefit and reduced injections in wet amd TradingView Wed, 03 Jun 2026 20:59:10 GMT
• fdmt: 4d-150 gene therapy shows promise for durable wet amd treatment with strong safety and scalability TradingView Wed, 03 Jun 2026 20:31:01 GMT
• insider sell alert: david kirn sells shares of 4d molecular therapeutics inc (fdmt) GuruFocus Wed, 03 Jun 2026 01:41:15 GMT
• Insider David Kirn sells 1,922 4D Molecular (NASDAQ: FDMT) shares Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• 4d molecular therapeutics CEO Kirn sells $19,257 in shares Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• insider sell alert: david kirn sells shares of 4d molecular ther GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• number of shareholders of 4d molecular therapeutics, inc. – nasdaq:fdmt TradingView Mon, 01 Jun 2026 18:13:20 GMT
• 4DMT Faces Investors with Pivotal Gene Therapy Data on the Line BriefGlance Wed, 27 May 2026 07:00:00 GMT
• biotech 4dmt heads to june jefferies and goldman investor events Stock Titan Wed, 27 May 2026 07:00:00 GMT
• 4d molecular therapeutics inc at rbc capital markets global healthcare conference transcript GuruFocus Wed, 20 May 2026 12:52:32 GMT
• 4d molecular therapeutics inc (fdmt): gene therapy stock made for you? Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• 4d molecular therapeutics, inc. - common stock (nq: fdmt FinancialContent Tue, 19 May 2026 20:00:01 GMT
• fdmt: pivotal global trials advance a disruptive, lifelong gene therapy for retinal disease TradingView Tue, 19 May 2026 07:00:00 GMT
• user | mammothtimes.com - 4d molecular therapeutics, inc. - common stock (nasdaq:fdmt) stock quote FinancialContent Sun, 17 May 2026 16:22:03 GMT
• user | malvern-online.com - 4d molecular therapeutics, inc. - common stock (nasdaq:fdmt) stock quote FinancialContent Sun, 17 May 2026 11:31:08 GMT
• 4d molecular therapeutics touts rapid phase 3 momentum for retinal gene therapy inkl Sun, 17 May 2026 00:18:30 GMT
• 4d molecular therapeutics touts rapid phase 3 momentum for retinal gene therapy The Globe and Mail Sat, 16 May 2026 07:00:00 GMT
• 4d molecular therapeutics inc. (fdmt) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 16 May 2026 00:31:00 GMT
• biotech 4d molecular therapeutics grants 141,100 rsus to new employees Stock Titan Fri, 15 May 2026 20:05:00 GMT
• fat pitch financials - 4d molecular therapeutics, inc. - common stock (nasdaq:fdmt) stock quote FinancialContent Fri, 15 May 2026 20:00:01 GMT
• bvf affiliates report 5.35m 4d shares (fdmt) and 8.48m pre-funded warrants Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ra capital affiliates report 9.99% of 4d molecular (nasdaq: fdmt) via warrants and shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• 4d molecular therapeutics inc at bank of america global healthcare conference transcript GuruFocus Thu, 14 May 2026 13:09:14 GMT
• chardan capital maintains 4d molecular therapeutics (fdmt) buy recommendation MSN Thu, 14 May 2026 01:37:31 GMT
• h.c. wainwright maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $36 富途牛牛 Wed, 13 May 2026 18:45:00 GMT
• fdmt: 4d-150's phase iii progress and robust data position it as a potential game-changer in retinal gene therapy TradingView Wed, 13 May 2026 07:00:00 GMT
• state street (fdmt) discloses 5.3% holdings — 2.7m shares reported on 03/31/2026 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• h.c. wainwright maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $36 Moomoo Mon, 11 May 2026 11:31:00 GMT
• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Analysts Have Made A Financial Statement On 4D Molecular Therapeutics, Inc.'s (NASDAQ:FDMT) First-Quarter Report simplywall.st Mon, 11 May 2026 07:00:00 GMT
• analyst reiterates buy on 4d molecular therapeutics as wet amd gene therapy advances, keeps $36 price target unchanged TipRanks Mon, 11 May 2026 07:00:00 GMT
• daniel giraldo reiterates buy on 4d molecular therapeutics, citing strong 4d-150 progress and undervalued upside vs. $29 price tar... TipRanks Sun, 10 May 2026 07:00:00 GMT
• 4d molecular therapeutics (nasdaq:fdmt) issues earnings results, misses estimates by $0.04 eps MarketBeat Sat, 09 May 2026 07:00:00 GMT
• 4d molecular therapeutics (nasdaq:fdmt) lowered to "sell" rating by wall street zen MarketBeat Sat, 09 May 2026 07:00:00 GMT
• chardan capital maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $26 Moomoo Fri, 08 May 2026 20:31:00 GMT
• rbc capital maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $35 富途牛牛 Fri, 08 May 2026 14:14:16 GMT
• 4d molecular price target lowered to $33 from $38 at goldman sachs TipRanks Fri, 08 May 2026 14:11:34 GMT
• goldman sachs maintains 4d molecular therapeutics(fdmt.us) with buy rating, cuts target price to $33 富途牛牛 Fri, 08 May 2026 12:35:00 GMT
• 4d molecular therapeutics, inc. stock 12‑month price target cut to $27.62, implies 178% upside TradingView Fri, 08 May 2026 08:20:02 GMT
• 4d molecular therapeutics (nasdaq:fdmt) shares gap down after earnings miss MarketBeat Fri, 08 May 2026 07:00:00 GMT
• 4d molecular therapeutics (nasdaq:fdmt) q1 2026: revenue miss and wider losses overshadow phase 3 progress ChartMill Fri, 08 May 2026 06:05:23 GMT
• 4d molecular therapeutics : quarterly report for quarter ending march 31, 2026 (form 10-q) marketscreener.com Thu, 07 May 2026 23:10:15 GMT
• 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• fdmt financials: income statement, balance sheet & cash flow Stock Titan Thu, 07 May 2026 07:00:00 GMT
• 4d molecular (nasdaq: fdmt) details q1 loss and cash runway to 2028 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• 4d molecular therapeutics (nasdaq: fdmt) files $400m shelf registration Stock Titan Thu, 07 May 2026 07:00:00 GMT
• wet amd gene therapy moves ahead; 4dmt targets 2027 phase 3 data Stock Titan Thu, 07 May 2026 07:00:00 GMT
• [10-q] 4d molecular therapeutics, inc. quarterly earnings report Stock Titan Thu, 07 May 2026 07:00:00 GMT
• 4d molecular therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• 4d molecular therapeutics (nasdaq:fdmt) q1 2026: revenue miss and wider losses overshadow phase 3 progress ChartMill Thu, 07 May 2026 07:00:00 GMT
• 4d molecular therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Thu, 07 May 2026 07:00:00 GMT
• 4d molecular therapeutics inc expected to post a loss of 99 cents a share - earnings preview TradingView Mon, 04 May 2026 07:00:00 GMT
• 4dmt management to present at bofa, rbc healthcare conferences Stock Titan Mon, 04 May 2026 07:00:00 GMT
• 4d molecular therapeutics to present at two major healthcare investor conferences in may 2026 Pluang Mon, 04 May 2026 07:00:00 GMT
• contact us - sherbrooke record - 4dmt to participate in upcoming investor conferences FinancialContent Mon, 04 May 2026 07:00:00 GMT
• 4d molecular therapeutics (fdmt) to release quarterly earnings on thursday MarketBeat Thu, 30 Apr 2026 07:00:00 GMT
4D Molecular Therapeutics, Inc(NASDAQ:FDMT) 
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has t...
Founded: 2013
CEO: David Kirn
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends